Izvorni Stručni Članak Original Professional Article Usporedba Reagensa Pathromtin Sl, Dade Actin Fs I Sta Cephascreen Za Određivanje Aktiviranog Parcijalnog Tromboplastinskog Vremena Comparability of Pathromtin Sl, Dade Actin Fs I Sta Cephascreen Reagents for Activated Partial Thromboplastin Time Measurement
نویسنده
چکیده
Cilj: Is pi ta ti ko re la ci ju vri jed nos ti APTV do bi ve nih ko riš te njem tri ju rea gen sa: Pat hrom tin SL i Da de Ac tin FS na ana li za to ru Be ric hrom Coa gu la tion System (BCS), od nos no STA Cep has creen na ana li za to ru STA Com pa ct. Ma te ri ja li i me to de: APTV je od re đen u 114 uzo ra ka svje že plaz me is pitanika, od ko jih je 46 li je če no nis ko mo le ku lar nim he pa ri nom, a os ta lih 68 ni je bilo na an ti koa gu lan tnoj te ra pi ji. Vri jed nos ti APTV od re đe ne su koagulometrijskom me to dom us po red no po mo ću sva tri rea gen sa ne pos red no nakon do no še nja uzo ra ka u koa gu la cij ski la bora to rij. Vri jed nos ti APTV od re đe ne su i u ko mer ci jal nim kon trol nim prip rav ci ma Lypoc he ck Coa gu la tion Con trol proiz vo đa ča Bio-Rad (Bio-Rad La bo ra to ries, SAD), ko ji obuh va ća ju tri raz li či ta ras po na vri jed nos ti. Re zul ta ti: Vri jed nos ti ko mer ci jal nih kon trol nih uzo ra ka Bio-Rad kre ta le su se unu tar ras po na što ga na vo di proiz vo đač za sva tri is pi ti va na rea gen sa. Kore la ci jom rea gen sa Pat hrom tin SL i Da de Ac tin FS, Pat hrom tin SL i STA Cep hascreen, te Da de Ac tin FS i STA Cep has creen do bi ve ne su izvr sne po ve za nos ti (R = 0,9485, 0,9353 i 0,9072). Is pi ta na je raz li ka iz me đu do bi ve nih koe fi ci je na ta ko re la ci je i na đe na je sta tis tič ki zna čaj na raz li ka iz me đu koe fi ci je na ta ko re la cije re zul ta ta do bi ve nih reagensima Pat hrom tin SL i Da de Ac tin FS. Pas si ng-Bablok reg re si jom vrijed nos ti na gi ba i od sječ ka na osi y obuh va ća le su 1 od nos no 0 sa mo u kom bi na ci ji rea gen sa Da de Ac tin FS i STA Cep has creen. Zak lju čak: Is pi ti va nje je po ka za lo da su naj bo lje us po re di ve vri jed nos ti do bive ne rea gen si ma Da de Ac tin FS i STA Cep has creen. Una toč izvr snoj po ve za nosti Pas si ng-Bab lok reg re si ja po ka za la je da su rea gen si Pat hrom tin SL i Da de Ac tin FS te Pat hrom tin SL i STA Cep has creen sla bi je us po re di vi. Ka ko do bi ve ni re zul ta ti pot vr đu ju opa ža nja iz sva kod nev nog ra da, bit no je da se bo les ni ci iz lo ženi he pa rin skom li je če nju ne pra te is todobno raz li či tim rea gen si ma zbog raz li či te os jet lji vos ti rea gen sa pre ma te ra pi ji nis ko mo le ku lar nim he pa ri nom. Ključ ne ri je či: ak ti vi ra no par ci jal no trom bop las tin sko vri je me, us po red ba me to da, koa gu la cij ski ana li za to ri Ab stra ct
منابع مشابه
Determination of APTT factor sensitivity – the misguiding guideline
INTRODUCTION The Clinical and Laboratory Standards Institute (CLSI) has produced a guideline detailing how to determine the activated partial thromboplastin time's (APTT) sensitivity to clotting factor deficiencies, by mixing normal and deficient plasmas. Using the guideline, we determined the factor sensitivity of two APTT reagents. METHODS APTTs were performed using Actin FS and Actin FSL o...
متن کاملUse of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin.
BACKGROUND The commonly recommended therapeutic range for patients receiving unfractionated heparin of 1.5 to 2.5 times the control activated partial thromboplastin time (aPTT) is not universally applicable. It has been suggested that the therapeutic range for each aPTT reagent should be based on plasma heparin levels. We sought to identify an aPTT ratio that corresponds to therapeutic anti--fa...
متن کاملDetecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
Background Traditional coagulation tests are included in emergency guidelines for management of patients on direct oral anticoagulants (DOACs) who experience acute bleeding or require surgery. We determined the ability of traditional coagulation tests and fast whole blood thromboelastography (ROTEM®) to screen for anticoagulation activity of dabigatran and rivaroxaban as low as 30 ng/mL. Meth...
متن کاملInterferences in coagulation tests--evaluation of the 570-nm method on the Dade Behring BCS analyser.
The Dade Behring BCS is a coagulation analyser with optical reaction detection (standard 405 nm). The present study was conducted to evaluate measurement at 570 nm for analyses in interfering plasma samples. Prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen and D-dimer in normal (n=50), lipaemic (n=60), icteric (n=113), and haemolytic (n=58) samples were measured a...
متن کاملProthrombin time derived fibrinogen determination on Sysmex CA-6000.
AIM To evaluate PT derived fibrinogen determinations with reference to the Clauss fibrinogen assay using a Sysmex CA-6000 random access coagulation analyser. METHODS Samples were analysed from normal subjects (n = 20), patients with renal or liver dysfunction (n = 25), critically ill patients (n = 25), patients receiving oral anticoagulant treatment (n = 50), and patients with a haemoglobinop...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2008